The global peptide therapeutics market value was USD 36.10 Billion in 2024, driven by the rising advancements in peptide synthesis technologies across the globe. The market size is anticipated to grow at a CAGR of 7.60% during the forecast period of 2025-2034 to achieve a value of USD 75.10 Billion by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Billion
2025-2034
Peptide Therapeutics Market Outlook
*this image is indicative*
The oral segment based on the route of administration is expected to account for a significant share in the market. The growing efforts by the drug developers to facilitate oral delivery of peptides due to the increased inclination of people towards minimally invasive treatments are likely to boost the segment growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Additionally, orally delivered peptide therapeutics facilitate patient compliance, diversify the treatment options, offer ease of administration, and boost marketability. These factors are likely to aid the market growth. Moreover, the expansion of the major biotechnology companies specialising in the oral delivery of peptides is anticipated to bolster the market growth in the forecast period.
The peptide therapeutics industry in North America is driven by factors such as the strong pharmaceutical and biopharmaceutical ecosystem in the region, easy access to medical facilities, and rapid growth in the development of therapeutic proteins. A considerable increase in the number of protein-based drugs, coupled with the increased investments to develop new therapeutic proteins for a wide range of ailments has supported the regional market expansion. In addition, the favourable government policies encouraging the sales of peptide-based drugs are anticipated to further aid the market growth in the region.
Peptide therapeutics can be defined as peptide-based therapeutics used to treat various diseases. Peptide therapeutics mimic the functions of the naturally occurring peptides in the human body, further serving as a promising basis for targeting a range of diseases. They are often well tolerated by the body and have the potential for decreased off-target side effects.
Market Breakup by Type:
Market Breakup by Applications:
Market Breakup by Route of Administration:
Market Breakup by Type of Manufactures:
Market Breakup by Distribution Channels:
Market Breakup by Region :
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The rising cases of chronic diseases and the increasing prevalence of cancer are driving the global peptide therapeutics industry. Additionally, there has been a significant surge in the incidences of metabolic diseases such as diabetes among the geriatric population. Unhealthy and poor lifestyles led by people with hectic and busy schedules are likely to increase the risk of various kinds of diseases, thereby enhancing the therapeutic use of peptide drugs for different treatments. Hence, these factors are likely to provide impetus to the peptide therapeutics industry. The complexity associated with large peptides is likely to restrain the market growth, however, the growing availability of biosimilars is expected to aid the market in the forecast period.
The report gives a detailed analysis of the following key players in the global peptide therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Peptide Therapeutics Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The peptide therapeutics were valued at USD 36.1 billion in 2024.
The market is expected to grow at a CAGR of 7.6% from 2025 to 2034 to reach a value of USD 69.9 billion by 2034.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the industry, such as the rising cases of chronic diseases such as cancer and tuberculosis, advancements in the field of medical science, and the growing healthcare spending, are expected to fuel the market growth.
The key market trends guiding the growth of the industry include the growing investments by the leading life sciences companies in research and development activities.
Generic and branded are the major marketing types considered within the market report.
Gastrointestinal disorders, neurological disorders, metabolic disorders, cancer, and cardiovascular, among others are the different applications of peptide therapeutics.
Parenteral, and oral, among others are the different routes of administration utilised in the industry.
The major players in the industry are Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Amgen Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup byType |
|
| Breakup by Applications |
|
| Breakup by Route of Administration |
|
| Breakup by Type of Manufactures |
|
| Breakup by Distribution Channels |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share